PMC:7536954 / 2474-2676
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T4 | 75-86 | Body_part | denotes | left axilla | http://purl.org/sig/ont/fma/fma45303 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T3 | 80-86 | Body_part | denotes | axilla | http://purl.obolibrary.org/obo/UBERON_0009472 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T38 | 113-115 | Disease | denotes | HS | http://purl.obolibrary.org/obo/MONDO_0006559 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T18 | 80-86 | http://www.ebi.ac.uk/efo/EFO_0001395 | denotes | axilla |
| T19 | 167-168 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T20 | 199-200 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | b |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T26 | 113-115 | Chemical | denotes | HS | http://purl.obolibrary.org/obo/CHEBI_74056 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 92 | 32-43 | Chemical | denotes | secukinumab | MESH:C555450 |
| 93 | 146-157 | Chemical | denotes | secukinumab | MESH:C555450 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T24 | 113-115 | Phenotype | denotes | HS | http://purl.obolibrary.org/obo/HP_0040154 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T22 | 0-52 | Sentence | denotes | Figure 1 Clinical response to secukinumab therapy. |
| T23 | 53-202 | Sentence | denotes | Manifestations at the left axilla consisted of inflammatory HS nodules and fistulas prior to secukinumab therapy (a) and after 20‐week treatment (b). |